Access to health
The diabetes epidemic affects today close to 285 million people according to IDF. It is estimated that within twenty years it will reach 438 million people. Most of these will be in developing countries. This situation calls for a concerted action to improve access to diabetes care in developing countries.
As a world leader in diabetes care, Novo Nordisk wants to ensure that more people with diabetes in developing countries have access to healthcare. The Novo Nordisk strategy for access to diabetes care is founded on our company's vision to defeat diabetes. It aims to improve the conditions for the next generations by protecting the most vulnerable and building partnerships and capacity to confront the diabetes epidemic in least developed countries and emerging economies.
The Novo Nordisk position on access to health, explains our approach to access to health. We have initiated a range of activities to improve access to health:
Children with diabetes
The life expectancy for a child with type 1 diabetes in much of sub-Saharan Africa is typically less than one year. A child with the same condition in the developed world has the possibility to live a full life...
See our latest annual report
World Partner Project
The purpose of the World Partner Project (WPP) is to establish a foundation on which developing countries can build their own healthcare strategies and ultimately...
See our latest annual report | | Woman with diabetes
Women are especially affected by diabetes due to various biological, cultural, and socio-economic factors. These factors not only place women at a disadvantage in obtaining diagnosis...
See our latest annual report
Best possible pricing
Novo Nordisk offers human insulin to the public health systems in the Least Developed Countries, as defined by the United Nations, at prices not exceeding 20%...
See our latest annual report |
In addition Novo Nordisk has created the following organisations:
World Diabetes Foundation
The WDF is dedicated to supporting the prevention and treatment of diabetes in the developing world through the funding of sustainable...
See our latest annual report
Visit WDF's website | | Haemophilia Foundation
Novo Nordisk Haemophilia Foundation was created in 2005 to address the significant need for improving haemophilia care in the developing...
See our latest annual report
Visit NNHF's website |
